These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10463754)

  • 21. Dupuytren's contracture: morphological and biochemical changes in palmar aponeurosis.
    Hamamoto H; Ueba Y; Sudo Y; Sanada H; Yamamuro T; Takeda T
    Hand; 1982 Oct; 14(3):237-47. PubMed ID: 6130030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unraveling the signaling pathways promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target.
    Verjee LS; Verhoekx JS; Chan JK; Krausgruber T; Nicolaidou V; Izadi D; Davidson D; Feldmann M; Midwood KS; Nanchahal J
    Proc Natl Acad Sci U S A; 2013 Mar; 110(10):E928-37. PubMed ID: 23431165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical expression and distribution of alpha2beta1, alpha6beta1, alpha5beta1 integrins and their extracellular ligands, type IV collagen, laminin and fibronectin in palmar fibromatosis.
    Magro G; Fraggetta F; Travali S; Lanzafame S
    Gen Diagn Pathol; 1997 Dec; 143(4):203-8. PubMed ID: 9489951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Involvement of M1 Macrophage and VLA4/VCAM-1 Pathway in the Valvular Damage Due to Rheumatic Heart Disease.
    Xian S; Li Y; Bai L; Tang S; Meng Z; Wen H; Huang F; Zeng Z
    Front Biosci (Landmark Ed); 2024 Jun; 29(6):219. PubMed ID: 38940032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease.
    Brickley-Parsons D; Glimcher MJ; Smith RJ; Albin R; Adams JP
    J Bone Joint Surg Am; 1981 Jun; 63(5):787-97. PubMed ID: 7240301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.
    Berndt A; Kosmehl H; Katenkamp D; Tauchmann V
    Pathobiology; 1994; 62(2):55-8. PubMed ID: 7524526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of CS1 moiety of fibronectin in VLA mediated haemopoietic progenitor trafficking.
    Craddock CF; Nakamoto B; Elices M; Papayannopoulou Th
    Br J Haematol; 1997 Apr; 97(1):15-21. PubMed ID: 9136937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Langerhans cells in Dupuytren's contracture.
    Qureshi FI; Hornigold R; Spencer JD; Hall SM
    J Hand Surg Br; 2001 Aug; 26(4):362-7. PubMed ID: 11469841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.
    Halliday NL; Rayan GM; Zardi L; Tomasek JJ
    J Hand Surg Am; 1994 May; 19(3):428-34. PubMed ID: 8056970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response to stimulation by TGF-beta1.
    Bisson MA; McGrouther DA; Mudera V; Grobbelaar AO
    J Hand Surg Br; 2003 Aug; 28(4):351-6. PubMed ID: 12849947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of growth factors on fibroblasts of Dupuytren's tissue and normal palmar fascia.
    Alioto RJ; Rosier RN; Burton RI; Puzas JE
    J Hand Surg Am; 1994 May; 19(3):442-52. PubMed ID: 8056971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of contractile force by cultured Dupuytren's disease and normal palmar fibroblasts.
    Rayan GM; Tomasek JJ
    Tissue Cell; 1994 Oct; 26(5):747-56. PubMed ID: 9437248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosomal abnormalities in Dupuytren's contracture and carpal tunnel syndrome.
    Bonnici AV; Birjandi F; Spencer JD; Fox SP; Berry AC
    J Hand Surg Br; 1992 Jun; 17(3):349-55. PubMed ID: 1624873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibronectin filaments and actin microfilaments are organized into a fibronexus in Dupuytren's diseased tissue.
    Tomasek JJ; Haaksma CJ
    Anat Rec; 1991 Jun; 230(2):175-82. PubMed ID: 1867394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA sequencing reveals a depletion of collagen targeting microRNAs in Dupuytren's disease.
    Riester SM; Arsoy D; Camilleri ET; Dudakovic A; Paradise CR; Evans JM; Torres-Mora J; Rizzo M; Kloen P; Julio MK; van Wijnen AJ; Kakar S
    BMC Med Genomics; 2015 Oct; 8():59. PubMed ID: 26446724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histogenesis of Dupuytren's disease: an immunohistochemical study of 30 cases.
    Shum DT; McFarlane RM
    J Hand Surg Am; 1988 Jan; 13(1):61-7. PubMed ID: 3351230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A study of Dupuytren's tissue with the scanning electron microscope.
    Legge JW; Finlay JB; McFarlane RM
    J Hand Surg Am; 1981 Sep; 6(5):482-92. PubMed ID: 7276480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The pathobiochemistry of Dupuytren's contracture].
    Bobiński R
    Chir Narzadow Ruchu Ortop Pol; 2009; 74(2):68-73. PubMed ID: 19514484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.